Full Name
Email Address
Phone Number
Person of Concern

Prescribing Exparel for pain management may help combat opioid addiction

The United States is struggling hard to curtail the opioid addiction epidemic. Dependence on opioids is a serious health concern in the U.S. because of an increasing number of people succumbing to its effects each year. And many more are queuing up outside addiction recovery centers, hoping the medical and behavioral interventions will help them get rid of their addiction to prescription medicines.

Various government agencies are busy implementing guidelines to curb the growing menace of opioid use disorders. Now, a potential antidote designed in New Jersey could help bring down the rampant effect of the burgeoning opioid crisis. Created as an anesthetic to reduce pain for prolonged periods after surgery the drug Exparel was made available in the market five years ago. The drug is not an opioid like other pain relievers – Percocet, Vicodin and Oxycodone – in that it does lead to an addiction. Clinicians have recommended this medicine to more than a million patients till date.

Exparel can lower risk of addiction

The discovery of this painkiller is indeed revolutionary, considering that patients can now manage their pain without getting addicted to opioids. While prescribing Exparel, clinicians can explain why they are not advising regular opioid painkillers and the harms they can do. In addition, the use of the drug can help reduce the length of hospitalization term and do away with the side effects of opioids like nausea and constipation. Apparently, the biggest advantage of this drug is that it can lower the possible risk of addiction.

Elaborating on the need for such medicines, Chief Executive Officer of Pacira Pharmaceuticals Dave Stack said, “I think what is really good is that patients are now understanding of the depth of the problem and are taking control of their own healthcare and are demanding opioid-free or reduced opioid at least post-surgical treatment strategies.” Pacira Pharmaceuticals owns all product rights to Exparel.

States like New Jersey are constantly issuing warnings while formulating methods to cut down on prescription opioid abuse. With renewed efforts by the federal government to fight the addiction crisis, it is quite likely that the use of Exparel will be included among the methods planned by the new task force headed by the New Jersey Governor Chris Christie.

Tackling growing opioid misuse

Most deaths due to drug abuse include people falling prey to heroin use or opioid overdose. As per the U.S. Centers for Disease Control and Prevention (CDC), 2014 was a record year for drug overdose deaths, with more than 60 percent of them resulting from opioids. Nearly 91 Americans succumb to opioid overdose every day. According to the American Society of Addiction Medicine (ASAM), among the 20.5 million Americans, aged 12 years and above, afflicted with substance use disorder in 2015, 2 million had a substance use disorder involving prescription painkillers, while 591,000 had been living with a substance use disorder involving heroin use. According to the National Institute on Drug Abuse (NIDA), opioid deaths have increased three times in the past 15 years.

Getting timely treatment for opioid addiction

An over-indulgence in anything, including something as innocuous as prescription opioids, can have adverse effects. However, addiction to opioids needs to be treated at opioids rehab centers. Any form of addiction is bad and harmful for health.

Sovereign Health, one of the leading opioids addiction treatment centers, offers customized treatment plans according to the nature and severity of the addiction problem of the patients. Call our 24/7 helpline number 855-683-9756 to know about the best opioids drug rehab centers in the U.S. You can chat online with one of our representatives to know about various opioids addiction rehab centers across the country.